Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever-Reference-Cited by-同舟云学术

Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever

Published:2019-05 Issue:3 Volume:224 Page:371-382
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Das Sayan,Chowdhury Rimi,Pal Ananda,Okamoto Keinosuke,Das Santasabuj^ORCID

Funder

Science and Engineering Research Board

Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Ministry of Education, Culture, Sport, Science & Technology in Japan

Japan Agency for Medical Research and Development (AMED)

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference64 articles.

1. Multiplex PCR for differential diagnosis of emerging typhoidal pathogens directly from blood samples;Ali;Epidemiol. Infect.,2009

2. Comment on: development of Vi conjugate--a new generation of typhoid vaccine;Arya;Expert Rev. Vaccines,2014

3. Detection of Vi-negative Salmonella enterica serovar typhi in the peripheral blood of patients with typhoid fever in the Faisalabad region of Pakistan;Baker;J. Clin. Microbiol.,2005

4. Multidrug-resistant Salmonella enterica serotype Typhi, Gulf of Guinea Region, Africa;Baltazar;Emerg. Infect. Dis.,2015

5. Immunity to intracellular Salmonella depends on surface-associated antigens;Barat;PLoS Pathog.,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal Salmonella serovars;Frontiers in Immunology;2024-01-09

2. Immunoprophylactic potential of recombinant outer membrane protein of Salmonella enterica serovar Typhi against enteric fever in BALB/c mice;Journal of King Saud University - Science;2024-01

3. Functionalized chitosan based nanotherapeutics to combat emerging antimicrobial resistance in bacterial pathogen;Materials Today Communications;2023-12

4. Biotechnology in India: An Analysis of ‘Biotechnology Industry Research Assistance Council’ (BIRAC)‐Supported Projects;ChemBioChem;2023-09-29

5. Immunogenicity and protective efficacy of nanoparticle formulations of L-SseB against Salmonella infection;Frontiers in Immunology;2023-06-30